These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Mice with podocyte-specific overexpression of wild type alpha-actinin-4 are healthy controls for K256E-alpha-actinin-4 mutant transgenic mice. Michaud JL; Stitt-Cavanaugh E; Endlich N; Endlich K; De Repentigny Y; Kothary R; Kennedy CR Transgenic Res; 2010 Apr; 19(2):285-9. PubMed ID: 19585264 [TBL] [Abstract][Full Text] [Related]
7. Mice deficient in alpha-actinin-4 have severe glomerular disease. Kos CH; Le TC; Sinha S; Henderson JM; Kim SH; Sugimoto H; Kalluri R; Gerszten RE; Pollak MR J Clin Invest; 2003 Jun; 111(11):1683-90. PubMed ID: 12782671 [TBL] [Abstract][Full Text] [Related]
8. α-Actinin 4 potentiates nuclear factor κ-light-chain-enhancer of activated B-cell (NF-κB) activity in podocytes independent of its cytoplasmic actin binding function. Zhao X; Hsu KS; Lim JH; Bruggeman LA; Kao HY J Biol Chem; 2015 Jan; 290(1):338-49. PubMed ID: 25411248 [TBL] [Abstract][Full Text] [Related]
9. Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis. Kaplan JM; Kim SH; North KN; Rennke H; Correia LA; Tong HQ; Mathis BJ; Rodríguez-Pérez JC; Allen PG; Beggs AH; Pollak MR Nat Genet; 2000 Mar; 24(3):251-6. PubMed ID: 10700177 [TBL] [Abstract][Full Text] [Related]
10. Familial focal segmental glomerulosclerosis (FSGS)-linked α-actinin 4 (ACTN4) protein mutants lose ability to activate transcription by nuclear hormone receptors. Khurana S; Chakraborty S; Lam M; Liu Y; Su YT; Zhao X; Saleem MA; Mathieson PW; Bruggeman LA; Kao HY J Biol Chem; 2012 Apr; 287(15):12027-35. PubMed ID: 22351778 [TBL] [Abstract][Full Text] [Related]
11. Disease-causing mutation in α-actinin-4 promotes podocyte detachment through maladaptation to periodic stretch. Feng D; Notbohm J; Benjamin A; He S; Wang M; Ang LH; Bantawa M; Bouzid M; Del Gado E; Krishnan R; Pollak MR Proc Natl Acad Sci U S A; 2018 Feb; 115(7):1517-1522. PubMed ID: 29378953 [TBL] [Abstract][Full Text] [Related]
12. Functional analysis of promoter mutations in the ACTN4 and SYNPO genes in focal segmental glomerulosclerosis. Dai S; Wang Z; Pan X; Wang W; Chen X; Ren H; Hao C; Han B; Chen N Nephrol Dial Transplant; 2010 Mar; 25(3):824-35. PubMed ID: 19666657 [TBL] [Abstract][Full Text] [Related]
13. Nonlinear viscoelasticity of actin transiently cross-linked with mutant α-actinin-4. Yao NY; Becker DJ; Broedersz CP; Depken M; Mackintosh FC; Pollak MR; Weitz DA J Mol Biol; 2011 Sep; 411(5):1062-71. PubMed ID: 21762701 [TBL] [Abstract][Full Text] [Related]
14. Proteostasis as a therapeutic target in glomerular injury associated with mutant α-actinin-4. Yee A; Papillon J; Guillemette J; Kaufman DR; Kennedy CRJ; Cybulsky AV Am J Physiol Renal Physiol; 2018 Oct; 315(4):F954-F966. PubMed ID: 29873512 [TBL] [Abstract][Full Text] [Related]
15. Three-layered proteomic characterization of a novel ACTN4 mutation unravels its pathogenic potential in FSGS. Bartram MP; Habbig S; Pahmeyer C; Höhne M; Weber LT; Thiele H; Altmüller J; Kottoor N; Wenzel A; Krueger M; Schermer B; Benzing T; Rinschen MM; Beck BB Hum Mol Genet; 2016 Mar; 25(6):1152-64. PubMed ID: 26740551 [TBL] [Abstract][Full Text] [Related]
17. Mutational analysis of ACTN4, encoding α-actinin 4, in patients with focal segmental glomerulosclerosis using HRM method. Safaříková M; Reiterová J; Safránková H; Stekrová J; Zidková A; Obeidová L; Kohoutová M; Tesař V Folia Biol (Praha); 2013; 59(3):110-5. PubMed ID: 23890478 [TBL] [Abstract][Full Text] [Related]
18. Mutational and Biological Analysis of alpha-actinin-4 in focal segmental glomerulosclerosis. Weins A; Kenlan P; Herbert S; Le TC; Villegas I; Kaplan BS; Appel GB; Pollak MR J Am Soc Nephrol; 2005 Dec; 16(12):3694-701. PubMed ID: 16251236 [TBL] [Abstract][Full Text] [Related]
19. Molecular analysis of NPHS2 and ACTN4 genes in a series of 33 Italian patients affected by adult-onset nonfamilial focal segmental glomerulosclerosis. Aucella F; De Bonis P; Gatta G; Muscarella LA; Vigilante M; di Giorgio G; D'Errico M; Zelante L; Stallone C; Bisceglia L Nephron Clin Pract; 2005; 99(2):c31-6. PubMed ID: 15627790 [TBL] [Abstract][Full Text] [Related]
20. Functional Validation of an Alpha-Actinin-4 Mutation as a Potential Cause of an Aggressive Presentation of Adolescent Focal Segmental Glomerulosclerosis: Implications for Genetic Testing. Feng D; Steinke JM; Krishnan R; Birrane G; Pollak MR PLoS One; 2016; 11(12):e0167467. PubMed ID: 27977723 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]